Correlation Between Lipocine and Artiva Biotherapeutics,
Can any of the company-specific risk be diversified away by investing in both Lipocine and Artiva Biotherapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lipocine and Artiva Biotherapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lipocine and Artiva Biotherapeutics, Common, you can compare the effects of market volatilities on Lipocine and Artiva Biotherapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lipocine with a short position of Artiva Biotherapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lipocine and Artiva Biotherapeutics,.
Diversification Opportunities for Lipocine and Artiva Biotherapeutics,
-0.39 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Lipocine and Artiva is -0.39. Overlapping area represents the amount of risk that can be diversified away by holding Lipocine and Artiva Biotherapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Artiva Biotherapeutics, and Lipocine is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lipocine are associated (or correlated) with Artiva Biotherapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Artiva Biotherapeutics, has no effect on the direction of Lipocine i.e., Lipocine and Artiva Biotherapeutics, go up and down completely randomly.
Pair Corralation between Lipocine and Artiva Biotherapeutics,
Given the investment horizon of 90 days Lipocine is expected to generate 0.97 times more return on investment than Artiva Biotherapeutics,. However, Lipocine is 1.03 times less risky than Artiva Biotherapeutics,. It trades about 0.01 of its potential returns per unit of risk. Artiva Biotherapeutics, Common is currently generating about 0.01 per unit of risk. If you would invest 676.00 in Lipocine on September 20, 2024 and sell it today you would lose (202.00) from holding Lipocine or give up 29.88% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 21.62% |
| Values | Daily Returns |
Lipocine vs. Artiva Biotherapeutics, Common
Performance |
| Timeline |
| Lipocine |
| Artiva Biotherapeutics, |
Lipocine and Artiva Biotherapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Lipocine and Artiva Biotherapeutics,
The main advantage of trading using opposite Lipocine and Artiva Biotherapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lipocine position performs unexpectedly, Artiva Biotherapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Artiva Biotherapeutics, will offset losses from the drop in Artiva Biotherapeutics,'s long position.| Lipocine vs. Emergent Biosolutions | Lipocine vs. Neurocrine Biosciences | Lipocine vs. Teva Pharma Industries | Lipocine vs. Haleon plc |
| Artiva Biotherapeutics, vs. Paltalk | Artiva Biotherapeutics, vs. SEI Investments | Artiva Biotherapeutics, vs. GAMCO Global Gold | Artiva Biotherapeutics, vs. Royalty Management Holding |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Complementary Tools
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| CEOs Directory Screen CEOs from public companies around the world | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |